DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

Clinical trial NCT07358078 · RECRUITING

Trial details

NCT number: NCT07358078
Sponsor: Alnylam Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Transthyretin Amyloidosis With Cardiomyopathy

Start date: 2026-01-09
Primary completion: 2030-10-23
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.